 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN COVIDDiagnostics--Applied DNA Sciences, Inc. NASDAQ: APDN the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing and nucleic acid-based technologies, today announced consolidated financial results for the three and nine months ended June 30, 2021. We delivered excellent year-over-year revenue growth in the fiscal third quarter while laying the groundwork to secure a recently awarded COVID-19 testing services contract that has potential to be th 